{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:38:27Z","timestamp":1794325107627,"version":"4.9.0"},"reference-count":117,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2069,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1111\/j.1365-2893.2009.01245.x","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T12:15:05Z","timestamp":1260360905000},"page":"1-15","source":"Crossref","is-referenced-by-count":136,"title":["Occult hepatitis B virus infection: a covert operation"],"prefix":"10.1111","volume":"17","author":[{"given":"F. B.","family":"Hollinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2008.01.023","article-title":"Occult hepatitis B virus in liver tissue of individuals without hepatic disease","volume":"48","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1473-3099(02)00345-6","article-title":"Occult hepatitis B","volume":"2","author":"Torbenson","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-135-9-200111060-00006","article-title":"Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus","volume":"135","author":"McMahon","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.mpg.0000243438.47334.07","article-title":"Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12\u00e2\u0080\u0083years\u00e2\u0080\u0099 follow-up in northern Greece","volume":"44","author":"Zacharakis","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0016-5085(94)90760-9","article-title":"A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal","volume":"106","author":"Villeneuve","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/0003-4819-118-3-199302010-00006","article-title":"The natural history of asymptomatic hepatitis B surface antigen carriers","volume":"118","author":"De Franchis","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB7|cit7","first-page":"19","article-title":"Long term follow-up of a large cohort of inactive HBsAg(+)\/HBeAg(-)\/anti-HBe(+) carriers in Greece","volume":"16","author":"Gigi","year":"2007","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.21299","article-title":"Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients","volume":"44","author":"Laras","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy","volume":"126","author":"Werle-Lapostolle","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1073\/pnas.93.9.4398","article-title":"Viral dynamics in hepatitis B virus infection","volume":"93","author":"Nowak","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB11|cit11","first-page":"61","article-title":"Assembly of hepadnaviral virions and subviral particles","volume":"168","author":"Ganem","year":"1991","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.510310235","article-title":"Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection","volume":"31","author":"Cacciola","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hep.21529","article-title":"Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma","volume":"45","author":"Pollicino","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI118902","article-title":"Long-lasting memory T cell responses following self-limited acute hepatitis B","volume":"98","author":"Penna","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","article-title":"The hepatitis B virus persists for decades after patients\u00e2\u0080\u0099 recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response","volume":"2","author":"Rehermann","year":"1996","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1537-2995.2008.01701.x","article-title":"Hepatitis B virus infection and transfusion medicine: science and the occult","volume":"48","author":"Hollinger","year":"2008","journal-title":"Transfusion"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1053\/j.gastro.2008.02.017","article-title":"The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection","volume":"134","author":"Zerbini","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/JVI.65.4.1836-1842.1991","article-title":"Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication","volume":"65","author":"Blum","year":"1991","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jmv.20119","article-title":"Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays","volume":"73","author":"Jeantet","year":"2004","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2893.2002.00344.x","article-title":"Occult hepatitis B virus infection and its clinical implications","volume":"9","author":"Hu","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1099\/0022-1317-81-5-1165","article-title":"High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum","volume":"81","author":"Weinberger","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/jhep.2001.26511","article-title":"Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference","volume":"34","author":"Jardi","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/bmj.307.6912.1095","article-title":"Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection","volume":"307","author":"Mimms","year":"1993","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hep.510250338","article-title":"Hepatitis C virus core and E2 protein expression in transgenic mice","volume":"25","author":"Pasquinelli","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.22951","article-title":"Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference","volume":"50","author":"Bellecave","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1440-1746.2008.05384.x","article-title":"Hepatitis B virus\/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment","volume":"23","author":"Chu","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0168-8278(00)80107-5","article-title":"Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands","volume":"32","author":"Madejon","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB29|cit29","first-page":"425","volume-title":"Gastroenterology Clinics of North America","author":"Hollinger","year":"2006"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1423-0410.2001.00003.x","article-title":"An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques","volume":"80","author":"Saldanha","year":"2001","journal-title":"Vox Sang"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/JCM.44.4.1390-1399.2006","article-title":"Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay","volume":"44","author":"Ronsin","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1128\/JCM.42.11.5199-5204.2004","article-title":"Assessment of the target-capture PCR hepatitis B virus (HBV) DNA quantitative assay and comparison with commercial HBV DNA quantitative assays","volume":"42","author":"Shyamala","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB33|cit33","unstructured":"Ferguson M Health A Lelie N et\u00c2\u00a0al. WHO Working Group on Hepatitis and HIV Diagnostic Kits: Report of a collaborative study to 1) assess the suitability of a candidate replacement International Standard for HBsAg and a reference panel for HBsAg and 2) to calibrate the candidate standard in IU World Health Organization"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2893.2009.01245.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2893.2007.00912.x","article-title":"Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus","volume":"14","author":"Gerlich","year":"2007","journal-title":"J Viral Hepat"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2893.2009.01245.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1002\/jmv.20610","article-title":"Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene","volume":"78","author":"Weber","year":"2006","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1309\/K5EM795VNGGFGBXX","article-title":"The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays","volume":"125","author":"La\u00e2\u0080\u0099ulu","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2893.2009.01245.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2893.2007.00910.x","article-title":"Hepatitis B virus genetic diversity and its impact on diagnostic assays","volume":"14","author":"Hollinger","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1423-0410.2003.00289.x","article-title":"Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening","volume":"84","author":"Minegishi","year":"2003","journal-title":"Vox Sang"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1537-2995.2004.04055.x","article-title":"Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy","volume":"44","author":"Kuhns","year":"2004","journal-title":"Transfusion"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0042-9007.2004.00406.x","article-title":"Occult hepatitis B virus infection: implications in transfusion","volume":"86","author":"Allain","year":"2004","journal-title":"Vox Sang"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB41|cit41","first-page":"471","article-title":"Minimal role of hepatitis B virus in posttransfusion non-A, non-B hepatitis in Taiwan: a study by polymerase chain reaction","volume":"90","author":"Wang","year":"1991","journal-title":"J Formos Med Assoc"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jinf.2009.02.013","article-title":"Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China","volume":"58","author":"Fang","year":"2009","journal-title":"J Infect"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jinf.2006.02.002","article-title":"Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea","volume":"54","author":"Kim","year":"2007","journal-title":"J Infect"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmv.1890320412","article-title":"Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction","volume":"32","author":"Shih","year":"1990","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1423-0410.1992.tb02495.x","article-title":"Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg","volume":"63","author":"Iizuka","year":"1992","journal-title":"Vox Sang"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/jhep.2001.25172","article-title":"Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely \u00e2\u0080\u009coccult\u00e2\u0080\u009d?","volume":"34","author":"Brechot","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.20025","article-title":"High prevalence of occult hepatitis B in Baltimore injection drug users","volume":"39","author":"Torbenson","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.20435","article-title":"Occult hepatitis B virus infection in a North American adult hemodialysis patient population","volume":"40","author":"Minuk","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0168-8278(02)00457-9","article-title":"Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection","volume":"38","author":"Besisik","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","volume":"46","author":"Raimondo","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199907013410104","article-title":"Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease","volume":"341","author":"Cacciola","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-9071(199804)54:4<249::AID-JMV3>3.0.CO;2-4","article-title":"Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients","volume":"54","author":"Koike","year":"1998","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jmv.20784","article-title":"Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection","volume":"79","author":"Castillo","year":"2007","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.510310232","article-title":"Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen","volume":"31","author":"Marusawa","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1172\/JCI116950","article-title":"Hepatitis B virus persistence after recovery from acute viral hepatitis","volume":"93","author":"Michalak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI5048","article-title":"Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis","volume":"104","author":"Coffin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/hep.20419","article-title":"Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection","volume":"40","author":"Coffin","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.1840180407","article-title":"Mortality follow-up of the 1942 epidemic of hepatitis B in the U.S. Army","volume":"18","author":"Norman","year":"1993","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/jhep.2003.50171","article-title":"Long-term histologic and virologic outcomes of acute self-limited hepatitis B","volume":"37","author":"Yuki","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0168-8278(00)80134-8","article-title":"Occult hepatitis B virus after acute self-limited infection persisting for 30\u00e2\u0080\u0083years without sequence variation","volume":"33","author":"Blackberg","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(74)91485-8","article-title":"Risk of transfusing blood containing antibody to hepatitis B surface antigen","volume":"2","author":"Aach","year":"1974","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1537-2995.2008.01961.x","article-title":"Hepatitis B virus traceback and lookback: factors to consider","volume":"49","author":"Hollinger","year":"2009","journal-title":"Transfusion"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1423-0410.2008.01017.x","article-title":"Occult hepatitis B infection in blood donors","volume":"94","author":"Reesink","year":"2008","journal-title":"Vox Sang"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1537-2995.2005.00198.x","article-title":"Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test","volume":"45","author":"Kleinman","year":"2005","journal-title":"Transfusion"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1537-2995.2008.01698.x","article-title":"PRISM hepatitis B surface antigen detection of hepatitis B virus minipool nucleic acid testing yield samples","volume":"48","author":"Linauts","year":"2008","journal-title":"Transfusion"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.0958-7578.2004.0486.x","article-title":"Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor","volume":"14","author":"Dreier","year":"2004","journal-title":"Transfus Med"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1537-2995.1995.35195090661.x","article-title":"Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients","volume":"35","author":"Mosley","year":"1995","journal-title":"Transfusion"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1537-2995.2001.41030329.x","article-title":"Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection","volume":"41","author":"Prince","year":"2001","journal-title":"Transfusion"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1386-6532(06)80004-1","article-title":"Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation","volume":"36","author":"Gerlich","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1537-2995.2007.01276.x","article-title":"Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program","volume":"47","author":"Satake","year":"2007","journal-title":"Transfusion"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2009.05.020","article-title":"Transfusion-transmitted hepatitis B virus infection","volume":"51","author":"Candotti","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/hep.510240608","article-title":"Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure","volume":"24","author":"Mason","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0140-6736(92)91530-L","article-title":"Hepatitis B virus and apparent fulminant non-A, non-B hepatitis","volume":"339","author":"Wright","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/ajcp\/104.5.588","article-title":"Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology","volume":"104","author":"Hytiroglou","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0140-6736(93)92607-U","article-title":"Occult HBV in NANB fulminant hepatitis","volume":"341","author":"Sallie","year":"1993","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0016-5085(93)90425-C","article-title":"Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis","volume":"104","author":"Feray","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/jhep.2001.23065","article-title":"Hepatitis B infection in patients with acute liver failure in the United States","volume":"33","author":"Teo","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0168-8278(00)00100-8","article-title":"High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology","volume":"34","author":"Chemin","year":"2001","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gut.47.3.429","article-title":"Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology","volume":"47","author":"Berasain","year":"2000","journal-title":"Gut"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/cncr.21702","article-title":"Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients","volume":"106","author":"Squadrito","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000187720","article-title":"Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C","volume":"51","author":"Matsuoka","year":"2008","journal-title":"Intervirology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/lt.21284","article-title":"Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C","volume":"14","author":"Shetty","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/jmv.20943","article-title":"Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C","volume":"79","author":"Mrani","year":"2007","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1254\/jphs.FM0070050","article-title":"Life style-related diseases of the digestive system: cell culture system for the screening of anti-hepatitis C virus (HCV) reagents: suppression of HCV replication by statins and synergistic action with interferon","volume":"105","author":"Ikeda","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jmv.21488","article-title":"Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus","volume":"81","author":"Tamori","year":"2009","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1572-0241.2008.01912.x","article-title":"Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis","volume":"103","author":"Stroffolini","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jmv.10353","article-title":"Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America","volume":"70","author":"Hsia","year":"2003","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1097\/01.ALC.0000079449.47468.B0","article-title":"Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection","volume":"27","author":"Uetake","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1128\/JVI.73.6.4713-4720.1999","article-title":"Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation","volume":"73","author":"Marusawa","year":"1999","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1053\/gast.1997.v113.pm9352871","article-title":"Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen","volume":"113","author":"Dickson","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/jlts.2001.20786","article-title":"De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population","volume":"7","author":"Prieto","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jhep.2006.05.001","article-title":"Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006)","volume":"45","author":"Samuel","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(94)90934-2","article-title":"\u00e2\u0080\u009cOccult\u00e2\u0080\u009d hepatitis B virus as source of infection in liver transplant recipients","volume":"343","author":"Chazouilleres","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-199501270-00014","article-title":"The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors","volume":"59","author":"Wachs","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/lt.500030202","article-title":"The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient","volume":"3","author":"Douglas","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/lt.20093","article-title":"Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance","volume":"10","author":"Ghisetti","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.hs.2003.09.013","article-title":"Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure","volume":"9","author":"Abdelmalek","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00007890-199708150-00011","article-title":"Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors","volume":"64","author":"Satterthwaite","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB99|cit99","first-page":"381","article-title":"Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV","volume":"22","author":"Di Stefano","year":"2009","journal-title":"J Nephrol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s10620-006-9421-9","article-title":"Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients?","volume":"51","author":"Kanbay","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.transproceed.2009.03.001","article-title":"Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation","volume":"41","author":"Stratta","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1399-3062.2005.00091.x","article-title":"Occult hepatitis B in renal transplant patients","volume":"7","author":"Peres","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/annonc\/mdp230","article-title":"Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier","volume":"20","author":"Fukushima","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00007890-199809150-00012","article-title":"Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc","volume":"66","author":"Dhedin","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jhep.2005.01.018","article-title":"Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area","volume":"42","author":"Hui","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bmt.1702571","article-title":"Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients","volume":"26","author":"Ilan","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/01.TP.0000151661.52601.FB","article-title":"Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection","volume":"79","author":"Onozawa","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ncpgasthep0740","article-title":"Avoid the tragedy of hepatitis B reactivation in immunosuppressed patients","volume":"4","author":"Foont","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.dld.2006.12.017","article-title":"Prophylaxis and treatment of hepatitis B in immunocompromised patients","volume":"39","author":"Marzano","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cgh.2006.05.027","article-title":"Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention","volume":"4","author":"Mindikoglu","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s15010-008-8194-9","article-title":"Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features","volume":"37","author":"Morsica","year":"2009","journal-title":"Infection"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.21422","article-title":"Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy","volume":"81","author":"Cohen Stuart","year":"2009","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2893.2009.01245.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijid.2008.08.018","article-title":"Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa","volume":"13","author":"Firnhaber","year":"2009","journal-title":"Int J Infect Dis"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2009.01245.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2893.2009.01245.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T08:34:00Z","timestamp":1625560440000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2009.01245.x"}},"subtitle":["Occult hepatitis B"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":117,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2009.01245.x","relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}